Together, activation of TR4 may be beneficial to prevent the PCa initiation in patients in which the expression of PPARγ is normal, while inhibiting TR4 via siRNA may be beneficial to prevent the PCa metastasis (Figure 1). Here, NR2C2 is linked to posterior cortical atrophy.